VPS4A Assay
A Transcreener Application
The VPS4A Assay uses the Transcreener ADP² Assay to directly detect ADP produced by VPS4A to measure enzymatic activity.
Run your enzyme reaction, add Transcreener reagents, and read your plates. The VPS4A assay is compatible with 96, 384, and 1536-well formats.
Z’ measurements using optimized VPS4A reaction conditions indicate a robust assay. Robust data like this is vital for sizeable, high-throughput screens that are difficult to complete due to the massive sample quantity. Z’ shown here = 0.91.
The assay demonstrates linearity when raw data is converted to ADP using a standard curve. Here, we use 2 µM ATP (sub-Km concentration) in a reaction buffer containing 50 mM HEPES (pH 7.5), 10 mM MgCl2, 50 mM KCl, 5 mM DTT, and 0.01% Triton at 37°C for two hours. Linearity is shown here under initial velocity conditions when raw data is converted to ADP formed.
Dose-response testing of selected hits from the pilot screen (BVT948 and Polygodial) and the control inhibitor (DBeQ) against VPS4A (175nM).
Interested in moving your program forward but don’t want to bring an assay in-house? Our scientists can help! BellBrook scientists will use their extensive biochemistry and enzymology expertise to work with you and accelerate your AAA ATPase program.
Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.
| Component | Notes |
|---|---|
| ADP² Antibody | Antibody specific to the nucleotide ADP. |
| ADP Tracer | When displaced, changes in fluorescence can be read in an FP, FI, or TR-FRET depending on the assay format. |
| Stop & Detect Buffer B, 10X for FP & FI, Stop & Detect Buffer C, 10X for TR-FRET | 200 mM HEPES (pH 7.5), 400 mM EDTA, and 0.2% Brij-35. Stops enzyme reactions requiring Mg²+. |
| ATP and ADP | ATP and ADP are used to create the ATP/ADP standard curve. ATP is used as a phosphate donor to start the reaction. |
VPS4A (Vacuolar Protein Sorting 4A) is a crucial protein that plays an essential role in the endosomal sorting complexes required for the transport (ESCRT) pathway. This pathway is vital for various cellular processes, including the sorting of membrane proteins, vesicle trafficking, and the formation of multivesicular bodies (MVBs). VPS4A belongs to the AAA ATPase family and is key to disassembling the ESCRT-III complex, which is critical for the final stages of endosomal sorting, as well as for processes such as cytokinesis, viral budding, and autophagy.
Given VPS4A’s involvement in these biological functions, it presents a promising therapeutic target for a range of diseases, including cancer, viral infections, and neurodegenerative disorders. Ongoing research into the inhibition or modulation of VPS4A may lead to novel therapeutic approaches that could improve existing treatments or create new methods to tackle difficult diseases.
Find the right resources to help you get to your solution faster.
Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.